Overview
Kirit Singh MD, MSc.
MBBS (MD Equivalent) - Barts and the London (2016)
MSc (Distinction) - Cardiff University (2021)
My primary research interests lie in neuro-oncology, and I currently work as a PhD candidate in the Brain Tumor Immunotherapy Program at Duke University. My past experiences include leading an effort to expand a Phase I trial of peptide vaccination in glioblastoma currently underway at Duke University, NC, USA for patients in Scotland. I completed an academic foundation internship in the UK and following this, I continued my surgical residency while also undertaking a MSc program evaluating novel surgical practices which I completed with distinction. I have continued to develop into my role as a physician-scientist and received an early career researcher grant from the Scottish Imaging Network. I was also appointed as an Honorary Clinical Lecturer at the University of Dundee, the institution where I undertook my internship. Since joining Duke, I have used these skills to support the team in developing investigational new drug applications. I have also helped to design multiple surgical window of opportunity trials in glioblastoma patients on which I am a named sub investigator, and also received the Paul and Lauren Ghaffari graduate oncology research fellowship award for my pre-clinical work.
MBBS (MD Equivalent) - Barts and the London (2016)
MSc (Distinction) - Cardiff University (2021)
My primary research interests lie in neuro-oncology, and I currently work as a PhD candidate in the Brain Tumor Immunotherapy Program at Duke University. My past experiences include leading an effort to expand a Phase I trial of peptide vaccination in glioblastoma currently underway at Duke University, NC, USA for patients in Scotland. I completed an academic foundation internship in the UK and following this, I continued my surgical residency while also undertaking a MSc program evaluating novel surgical practices which I completed with distinction. I have continued to develop into my role as a physician-scientist and received an early career researcher grant from the Scottish Imaging Network. I was also appointed as an Honorary Clinical Lecturer at the University of Dundee, the institution where I undertook my internship. Since joining Duke, I have used these skills to support the team in developing investigational new drug applications. I have also helped to design multiple surgical window of opportunity trials in glioblastoma patients on which I am a named sub investigator, and also received the Paul and Lauren Ghaffari graduate oncology research fellowship award for my pre-clinical work.